EIF5A2 and hepatocellular carcinoma: Other miRNAs, such as miR-138 and miR-9, interact with their respective target genes in HCC, specifically, Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) and Eukaryotic Translation Initiation Factor 5A2 (EIF5A2), to affect EMT and induce cisplatin sensitivity [79,80].